Ozempic Fetal Oxygen Study: What the Sheep Data Show
The Ozempic fetal oxygen study is a small animal experiment from Adelaide University. Seven pregnant sheep got one dose of semaglutide, the drug in Ozempic and Wegovy. Within two hours the mothers' hearts pumped less blood, less blood reached the uterus, and oxygen in the fetal blood fell about 19%. It has not been tested in people and the full paper is not out yet. The labels already say to stop semaglutide at least 2 months before a planned pregnancy, so call your prescriber if you are pregnant or trying. If you are on a GLP-1 and not planning a baby, Sharpy helps you protect muscle with one protein target, one 20-minute workout and one Shape Score a day.
What is the Ozempic fetal oxygen study, and should it worry you? It is a small animal experiment from Adelaide University in Australia. Researchers gave one dose of semaglutide, the drug in Ozempic and Wegovy, to seven pregnant sheep. Within two hours, the mothers' hearts pumped less blood, less blood reached the uterus, and oxygen in the fetal blood dropped by about 19%. It is an early finding in animals. Nobody has tested it in people. And the labels already say not to use semaglutide for weight loss during pregnancy.
News sites picked the story up between November 10 and 12, 2026. Here is what the study did, what it did not do, and what to do if this is about you.
What did the Ozempic fetal oxygen study find?
The team placed thin tubes in a fetal artery and a vein in the mother so they could take blood samples. A few days later they scanned each sheep with MRI before the dose, about 20 minutes after, and two hours after.
| Detail | What was reported |
|---|---|
| Who ran it | Adelaide University, Australia. Authors include Cho, Lock and Holman. |
| Animals | 7 pregnant sheep |
| Stage of pregnancy | Late. Tubes placed at 113 to 116 days, scans at 117 to 119 days. A sheep pregnancy lasts about 147 days. |
| Dose | One 0.75 mg infusion of semaglutide |
| Mother's heart output at 2 hours | Down 0.80 liters per minute (95% CI 0.09 to 1.52) |
| Blood flow in the uterine artery | Down 0.42 liters per minute (95% CI 0.09 to 0.75) |
| Mother's and fetus's blood pressure and heart rate | No significant change |
| Oxygen in fetal artery blood | 23.25 mmHg before, 19.94 at 45 minutes, 18.82 at 2 hours |
| Where it is published | An abstract in Heart, Lung and Circulation. The full paper is not out. |
Two notes help you read the table.
First, a fetus always has much less oxygen in its blood than an adult does. Low numbers are normal there. The news is the drop, from 23.25 to 18.82. That is about 19% lower in two hours.
Second, the share of the mother's blood going to the uterus did not change. The uterus got less because the heart was pumping less overall.
Why would semaglutide lower fetal oxygen?
The researchers do not know yet. Lead author Mitchell Lock told Newsweek it is "currently unknown what causes this change in blood flow."
His team has a guess. Blood vessels in the mother's uterus may carry the GLP-1 receptor, the same docking point the drug uses elsewhere in the body. If so, the drug could change blood flow there. Lock said the team does not think the drug acts on the fetus directly, because semaglutide is thought to be too large a molecule to cross the placenta.
That is a hypothesis, not a result. A second animal study of longer-term use is under way.
What the study does not show
This matters as much as the findings.
- It is not a human study. Lock said plainly that nobody knows if people respond the same way.
- It is tiny. Seven animals. Small studies can be wrong in either direction.
- It lasted two hours. No one measured whether the lambs grew less or were born smaller.
- It was one dose given into a vein, late in pregnancy. People take semaglutide as a weekly shot under the skin or a daily pill. And the usual real-life case is the opposite end of pregnancy: a woman on the drug who finds out she is a few weeks along.
- It is only an abstract. The full methods have not been through peer review as a complete paper.
So the study raises a question. It does not answer one.
Does Ozempic affect fetal development?
There is no clear human answer. Here is what the official labels say today.
| Label | What it says about pregnancy |
|---|---|
| Ozempic (type 2 diabetes) | Human data are limited. Based on animal studies, "there may be potential risks to the fetus." Use in pregnancy only if the benefit justifies the risk. Stop at least 2 months before a planned pregnancy. |
| Wegovy (weight loss) | Weight loss "offers no benefit to a pregnant patient and may cause fetal harm." Stop when a pregnancy is recognized if you take it for weight loss. Stop at least 2 months before a planned pregnancy. |
The older animal studies behind those lines were done in rats, rabbits and monkeys. They found pregnancy losses and birth defects at doses close to human doses. The labels note this happened alongside large weight loss in the mothers, so it is hard to separate the drug from the weight loss.
Human data so far are more calming, but thin. A 2024 study in JAMA Internal Medicine looked at early-pregnancy GLP-1 exposure in several countries and found no higher rate of major birth defects than with insulin. The authors called their estimates imprecise. Our Ozempic babies guide walks through that data.
The sheep study adds something new: a possible effect on blood flow late in pregnancy, which the birth-defect studies were not built to see.
What to do if you are pregnant or trying
This part belongs to your doctor, not to a website. A few label facts can help you start that talk.
- You are pregnant and on semaglutide. Call your prescriber or OB-GYN now. Do not wait for your next visit. If you take it for type 2 diabetes, do not stop on your own, because high blood sugar in pregnancy carries its own risks. Let your doctor set the plan.
- You are planning a pregnancy. Both labels say to stop at least 2 months before. Semaglutide leaves the body slowly. Work out the timing with your prescriber.
- You are not planning one. Weight loss can raise fertility, and Lock pointed out that many women do not know they are pregnant in the early weeks. Ask your prescriber about birth control. Our guide on Mounjaro and birth control explains why the pill needs extra care on tirzepatide.
- You took Wegovy while pregnant. The Wegovy label lists a pregnancy registry run by Novo Nordisk at 1-877-390-2760. Reports like yours are how better human data get built.
For the bigger picture on timing, see GLP-1 and pregnancy.
If you are on a GLP-1 and pregnancy is not in the picture
Then this study changes nothing about your treatment. It is still a good reminder that fast weight loss asks a lot of the body, and the basics matter: enough food, enough protein and regular strength work.
That is the gap Sharpy fills. It gives you one daily protein target, one 20-minute workout and one Shape Score, so you can see whether you are losing fat or losing muscle. Sharpy is not a medical or pregnancy app and it does not give advice on medication. Our Ozempic muscle loss guide covers what the trials show about lean mass.
What happens next
Three things to watch:
- The full paper. It will show the methods and let other scientists check the numbers.
- The longer animal study. Lock's team is testing ongoing use, which is closer to real life than a single dose.
- Human registry data. These build slowly, one reported pregnancy at a time.
We will update this guide when any of those land. Until then, the takeaway is simple. This is one small animal study, the label advice has not changed, and any decision about your medication belongs with your prescriber.
If you are staying on your GLP-1, Sharpy keeps the daily basics in one place: protein, a short workout and a score that tells you how your shape is changing.
Sources
- Newsweek: Ozempic may reduce oxygen supply to developing fetuses, animal study finds
- Cho, Lock, Holman et al., Do Weight Loss Drugs Impair Fetal Growth? Heart, Lung and Circulation (abstract)
- The Brighter Side of News / Adelaide University: Ozempic and Wegovy use during pregnancy (Nov 10, 2026)
- Earth.com: Semaglutide study raises new questions about pregnancy safety (Nov 10, 2026)
- Ozempic prescribing information, sections 8.1 and 8.3 (DailyMed)
- Wegovy prescribing information, sections 8.1 and 8.3 (DailyMed)
- Cesta et al., JAMA Internal Medicine 2024
Questions people ask
What is the Ozempic fetal oxygen study?
It is an animal experiment by researchers at Adelaide University in Australia. They gave one 0.75 mg dose of semaglutide to seven pregnant sheep late in pregnancy. Within two hours the mother's heart output and uterine blood flow dropped, and the oxygen level in fetal blood fell from 23.25 to 18.82 mmHg. So far it is published only as an abstract in the journal Heart, Lung and Circulation.
Does Ozempic affect fetal development in humans?
Nobody knows yet. The sheep study lasted two hours and did not measure growth. The Ozempic label says human data are limited and that animal studies point to potential risks to the fetus. The lead researcher said it is not known whether the same response happens in people.
Can you take Ozempic while pregnant?
The labels advise against it for weight loss. The Wegovy label says to stop when a pregnancy is recognized. The Ozempic label says to use it in pregnancy only if the benefit justifies the risk to the fetus, which is a decision for a diabetes doctor. Call your prescriber right away if you are pregnant.
What happens if you get pregnant on Ozempic?
Call your prescriber or OB-GYN as soon as you know. Do not decide alone. One large 2024 study in JAMA Internal Medicine found no higher rate of major birth defects after early GLP-1 exposure compared with insulin, but the authors called the estimates imprecise. Your doctor will tell you what to do about the medication.
How long before pregnancy should you stop Ozempic?
Both the Ozempic and Wegovy labels say to stop at least 2 months before a planned pregnancy. The reason is that semaglutide leaves the body slowly. Plan the timing with your prescriber, especially if you take it for type 2 diabetes.
Does semaglutide cross the placenta?
The study's lead author, Mitchell Lock, told Newsweek the current thinking is that it does not, because the molecule is large. His team thinks the drug acted on the mother's blood flow, not on the fetus directly. That is a hypothesis. The cause of the drop is still unknown.
Do the Ozempic animal study results apply to Mounjaro or Zepbound?
The sheep study tested semaglutide only. It did not test tirzepatide, the drug in Mounjaro and Zepbound. Those drugs have their own pregnancy warnings on their labels. Ask your prescriber about the drug you take.